AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
14 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
13 Mar 2012 07:00 AM
RNS
Files lawsuit against FDA decision on quetiapine
13 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
12 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
09 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
08 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
07 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
06 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
02 Mar 2012 02:00 PM
RNS
Share Repurchase Programme
02 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
01 Mar 2012 04:00 PM
RNS
Total Voting Rights
01 Mar 2012 07:00 AM
RNS
Announces Non-Executive and Chairman changes
29 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
28 Feb 2012 05:30 PM
RNS
Director/PDMR Shareholding
28 Feb 2012 05:30 PM
RNS
Director/PDMR Shareholding
28 Feb 2012 05:30 PM
RNS
Director/PDMR Shareholding
28 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
27 Feb 2012 05:30 PM
RNS
Director/PDMR Shareholding
27 Feb 2012 05:30 PM
RNS
Director/PDMR Shareholding
27 Feb 2012 05:30 PM
RNS
Director/PDMR Shareholding
27 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
24 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
23 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
22 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
21 Feb 2012 08:00 AM
RNS
EU approves Caprelsa for thyroid cancer
21 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
20 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
17 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
16 Feb 2012 07:00 AM
RNS
Director Declaration
16 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
15 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
14 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
13 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
10 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
09 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
08 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
07 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
06 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
03 Feb 2012 04:30 PM
RNS
Holding(s) in Company
03 Feb 2012 03:30 PM
RNS
Director/PDMR Shareholding
03 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
02 Feb 2012 01:00 PM
RNS
Share Repurchase Programme
02 Feb 2012 07:05 AM
RNS
Transaction in Own Shares
02 Feb 2012 07:01 AM
RNS
Final Results - Part 3 of 3
02 Feb 2012 07:00 AM
RNS
Final Results - Part 2 of 3
02 Feb 2012 07:00 AM
RNS
Final Results - Part 1 of 3
01 Feb 2012 04:00 PM
RNS
Total Voting Rights
01 Feb 2012 09:00 AM
RNS
Notice of Results
01 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
31 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100